| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 06/12/2002 | EP1213289A1 N-benzenesulfonyl L-proline compounds as bradykinin antagonists |
| 06/12/2002 | EP1213028A1 Hm1.24 antigen expression potentiators |
| 06/12/2002 | EP1212616A2 Inhibitors of binding between proteins and macromolecular ligands |
| 06/12/2002 | EP1212464A2 Diagnostics and therapeutics for osteoporosis |
| 06/12/2002 | EP1212362A2 Card proteins involved in cell death regulation |
| 06/12/2002 | EP1212355A2 Pharmaceutical compositions and methods of using secreted frizzled related protein |
| 06/12/2002 | EP1212344A1 B7-like polynucleotides, polypeptides, and antibodies |
| 06/12/2002 | EP1212335A1 Glucopyranosides conjugates of 2-(4-hydroxy-phenyl)-1- 4-(2-amin-1-yl-ethoxy)-benzyl]-1h-indol-5-ols |
| 06/12/2002 | EP1212330A1 Androgen receptor modulator compounds and methods |
| 06/12/2002 | EP1212328A1 Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage |
| 06/12/2002 | EP1212327A2 Pyrazolopyrimidines as therapeutic agents |
| 06/12/2002 | EP1212323A2 Substituted pyridino pentaazamacrocyle complexes having superoxide dismutase activity |
| 06/12/2002 | EP1212317A1 Indole derivatives and their use for the treatment of osteoporosis amongst other applications |
| 06/12/2002 | EP1212315A1 Novel chalcones |
| 06/12/2002 | EP1212313A1 7-carboxy-flavone derivatives, preparation method and therapeutic use |
| 06/12/2002 | EP1212312A1 Novel derivatives of flavones, xanthones and coumarins |
| 06/12/2002 | EP1212311A1 Chalcone coumarins |
| 06/12/2002 | EP1212309A1 Caspase inhibitor |
| 06/12/2002 | EP1212302A1 Compounds and pharmaceutical compositions as cathepsin s inhibitors |
| 06/12/2002 | EP1212299A1 Substituted piperidine compounds useful as modulators of chemokine receptor activity |
| 06/12/2002 | EP1212296A1 Phosphate mimics and methods of treatment using phosphatase inhibitors |
| 06/12/2002 | EP1212106A1 Phospholipid-coated implants |
| 06/12/2002 | EP1212087A1 Methods and compositions utilizing rad51 |
| 06/12/2002 | EP1212086A1 Immunological tolerance-induction agent |
| 06/12/2002 | EP1212077A2 Pharmaceutical composition of nateglinide and another antidiabetic agent |
| 06/12/2002 | EP1212067A1 Uses of diterpenoid triepoxides as an anti-proliferative agent |
| 06/12/2002 | EP1032571B1 Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance p antagonists |
| 06/12/2002 | EP1023263B1 Novel vitamin d analogues |
| 06/12/2002 | EP0929517B1 Hydroxamic acid derivatives |
| 06/12/2002 | EP0888327B1 Benzopyran derivatives having leukotriene-antagonistic action |
| 06/12/2002 | EP0885204B1 Novel aryl glycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds |
| 06/12/2002 | EP0688211B1 Thalidomide for inhibition of angiogenesis |
| 06/12/2002 | CN1353754A Variants of TRAF2 which act as an inhibitor of TNF-alpha (TNF alpha) signaling pathway |
| 06/12/2002 | CN1353713A Purine inhibitors of cyclin dependent kinase 2 and IK B-alpha |
| 06/12/2002 | CN1353706A Integrin receptor ligands |
| 06/12/2002 | CN1353704A 取代吡唑化合物 A substituted pyrazole compound |
| 06/12/2002 | CN1353702A Adamantane derivatives |
| 06/12/2002 | CN1353701A Peptidyl heterocyclic ketones useful as tryptase inhibitors |
| 06/12/2002 | CN1353699A Substituted bicyclic heterocycles, process for their preparation and their use as antiobesity and hypocholesterolemic agents |
| 06/12/2002 | CN1353697A 4-phenyl-pyrimidine derivatives |
| 06/12/2002 | CN1353695A Heterocyclically substituted benzimidazoles, production and application thereof |
| 06/12/2002 | CN1353690A Bradykinin receptor antagonists |
| 06/12/2002 | CN1353613A Pharmaceutical compositions |
| 06/12/2002 | CN1353610A Medicinal composition for oral administration |
| 06/12/2002 | CN1353606A IL-8 receptor antagonists |
| 06/12/2002 | CN1353185A Recombinant adenovirus of bone morphogenetic protein and its method for exciting bone generation |
| 06/12/2002 | CN1352989A Medical wine 'Sansan' for treating hyperosteogeny |
| 06/12/2002 | CN1352979A Chinese medicine for replenishing vital energy and promoting blood circulation |
| 06/12/2002 | CN1352961A Mongolian medicine prepared by enzyme engineering for treating bone injury and its preparing process |
| 06/12/2002 | CN1352957A Medicine for treating cervical vertebra disease |
| 06/11/2002 | US6404779 System and method of disharmonic frequency multiplexing |
| 06/11/2002 | US6403830 Amidino compound and salts thereof useful as nitric oxide synthase inhibitors |
| 06/11/2002 | US6403792 Sulfonyl isatin compounds and methods of blocking apoptosis therewith |
| 06/11/2002 | US6403791 Treatment of inflammatory diseases or autoimmune diseases in humans or animals |
| 06/11/2002 | US6403615 Treats osteoporosis, hyperlipidemia, and cardiovascular disorders associated with menopause; side effect reduction compared to estrogen-replacement therapy |
| 06/11/2002 | US6403614 Such as 2-(4-(methylthiomethoxy)phenyl)-3-(4-(2-piperidin-1-yl)ethoxy) benzoyl)-6-methylthiomethoxybenzo(b)thiophene;inhibition of osteoporosis, hyperlipedemia, cancer, postmenopausal syndrome, |
| 06/11/2002 | US6403613 Anti-inflammatory agent that reduces levels of cytokines (including tumor necrosis factor) |
| 06/11/2002 | US6403596 Substituted pyridones having cytokine inhibitory activity |
| 06/11/2002 | US6403586 Interleukin inhibitors |
| 06/11/2002 | US6403577 Hexamethyleneiminyl tachykinin receptor antagonists |
| 06/11/2002 | US6403349 Elongation of polyunsaturated fatty acid such as linolenic acid to dihomogamma linolenic acid; nucleotide sequence encodes polypeptide; genetic engineering; animal feeds, nutrients, cosmetics |
| 06/11/2002 | US6403345 Culturing, fermentation, obtaining biomass; purification; foods, drugs, cosmetics |
| 06/11/2002 | US6403091 Produced by the hybridoma having atcc accession no. hb 10916. |
| 06/11/2002 | CA2276614C Analogs of parathyroid hormone |
| 06/06/2002 | WO2002044380A2 Master bone formation transcription factor: compositions and methods of use |
| 06/06/2002 | WO2002044342A2 Hematopoietic cell e-selection/l-selectin ligand polypeptides and methods of use thereof |
| 06/06/2002 | WO2002044320A2 Human elongase genes and uses thereof |
| 06/06/2002 | WO2002044218A1 Compound of hydroxamic acid derivative and hyaluronic acid |
| 06/06/2002 | WO2002044209A2 Cytonkine receptor zcytor19 |
| 06/06/2002 | WO2002044203A2 Production of recombinant bmp-2 |
| 06/06/2002 | WO2002044183A2 Benzoazepine and benzodiazepine derivatives and their use as parp inhibitors |
| 06/06/2002 | WO2002044168A2 Indole-type inhibitors of p38 kinase |
| 06/06/2002 | WO2002044165A1 Quinoline derivatives as nk-3 antagonists |
| 06/06/2002 | WO2002044158A1 Salts of a isothiazole-4-carboxamide and their use as anti-hyperproliferation agents |
| 06/06/2002 | WO2002044154A1 Novel compounds |
| 06/06/2002 | WO2002044153A1 4-6-diphenyl pyridine derivatives as antiinflammatory agents |
| 06/06/2002 | WO2002044128A2 Salicylate analogs as interleukin-4 antagonists |
| 06/06/2002 | WO2002044120A1 Compounds active at the glucocorticoid receptor iii |
| 06/06/2002 | WO2002043774A2 Compositions and therapeutical use of polynucleotides encoding tcrs |
| 06/06/2002 | WO2002043763A2 Combination of gaba agonists and aldose reductase inhibitors |
| 06/06/2002 | WO2002043759A2 Method and composition for modulating bone growth |
| 06/06/2002 | WO2002043755A1 Use of bromelain for the treatment of inflammatory diseases and for adjuvant therapy during wound healing processes |
| 06/06/2002 | WO2002043738A2 Use of bisphosphonates for pain treatment |
| 06/06/2002 | WO2002043734A1 Novel compounds |
| 06/06/2002 | WO2002043728A1 Fatty acid analogues for the treatment of inflammatory and autoimmune disorders |
| 06/06/2002 | WO2002043721A1 Treatment of statin side effects |
| 06/06/2002 | WO2002043653A2 Crystalline glucosamine sulphate metal salts |
| 06/06/2002 | WO2002043648A2 Compounds active at the glucocorticoid receptor ii |
| 06/06/2002 | WO2002022616A3 Alpha v integrin receptor antagonists |
| 06/06/2002 | WO2002018320A3 INHIBITORS OF α4 MEDIATED CELL ADHESION |
| 06/06/2002 | WO2002014314A3 Substituted pyrazoles |
| 06/06/2002 | WO2002012242A3 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 06/06/2002 | WO2002003920A3 Method for treatment of reactive arthritis or bursitis |
| 06/06/2002 | WO2001094293A3 Benzamide ligands for the thyroid receptor |
| 06/06/2002 | WO2001090334A3 Drug metabolizing enzymes |
| 06/06/2002 | WO2001090129A3 Prophylactic and therapeutic treatment of infectious, autoimmune and allergic diseases with mono and disaccharide-base compounds |
| 06/06/2002 | WO2001090068A3 Mannich base prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use a modulators of protein kinases |
| 06/06/2002 | WO2001087849A3 Modulators of tnf- alpha signaling |
| 06/06/2002 | WO2001079442A3 Albumin fusion proteins |
| 06/06/2002 | WO2001072323A3 Use of insulin for the treatment of cartilagenous disorders |